Molecules preferentially associated with effector T cells and methods of their use

Details for Australian Patent Application No. 2003290688 (hide)

International Classifications

Event Publications

8 April 2004 Complete Application Filed

Priority application(s): 60/424,777 08.11.02 US; 60/467,477 02.05.03 US

8 July 2004 Application Open to Public Inspection

Published as AU-B-2003290688

3 April 2008 Application Accepted

Published as AU-B-2003290688

10 April 2008 Alteration of Name

The name of the applicant has been altered to Tolerx, Inc. Amendments 2004

24 April 2008 Corrigenda

Applications Accepted - Name Index Under the name TolerRx, Inc., Application No. 2003290688, under INID(71) correct the applicant name to read Tolerx, Inc.

31 July 2008 Standard Patent Sealed

3 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.